Literature DB >> 17651373

Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood.

Bengt Björkstén1, Tadd Clayton, Philippa Ellwood, Alistair Stewart, David Strachan.   

Abstract

In Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC) time trends in the prevalence of rhinoconjunctivitis symptoms were analysed. Cross-sectional questionnaire surveys with identical protocols and questionnaires were completed a mean of 7 yr apart in two age groups comprising 498,083 children. In the 13- to 14-yr age group 106 centres in 56 countries participated, and in the 6- to 7-yr age group 66 centres in 37 countries participated. A slight worldwide increase in rhinoconjunctivitis prevalence was observed, but the variations were large among the centres and there was no consistent regional pattern. Prevalence increases in the older children exceeding 1% per year were recorded in 13 centres, including 3 of 9 centres in Africa, 2 of 15 in Asia-Pacific, 1 of 8 in India, 3 of 15 in Latin America, 3 of 9 in Eastern Europe and 1 of 34 in Western and Northern Europe. Decreasing rhinoconjunctivititis prevalence of similar magnitude was only seen in four centres. The changes were less pronounced in the 6- to 7-yr-old children and only in one centre did any change exceed 1% per year. The decrease in highest prevalence rates in ISAAC Phase I suggests that the prevalence has peaked in those regions. An increase was recorded in several centres, mostly in low and mid-income countries. The increases were more pronounced in the older age group, suggesting that environmental influences on the development of allergy may not be limited to early childhood.

Entities:  

Mesh:

Year:  2007        PMID: 17651373     DOI: 10.1111/j.1399-3038.2007.00601.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  86 in total

1.  Pollen loads and allergic rhinitis in Darwin, Australia: a potential health outcome of the grass-fire cycle.

Authors:  Fay H Johnston; Ivan C Hanigan; David M J S Bowman
Journal:  Ecohealth       Date:  2009-05-08       Impact factor: 3.184

2.  Role of leptin in allergic rhinitis during sublingual immunotherapy.

Authors:  Yanhui Wen; Lifeng Zhou; Yuqiu Li; Zhengmin Li; Weijun Deng; Tao Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-14       Impact factor: 2.503

3.  Sublingual Immunotherapy Decreases Expression of Interleukin-33 in Children with Allergic Rhinitis.

Authors:  Yuanming Wang; Chuling Li; Yaxiong Xu; Deyu Xu; Gang Yang; Fang Liao; Xianglin Luo
Journal:  Indian J Pediatr       Date:  2018-05-23       Impact factor: 1.967

Review 4.  Modified allergens and their potential to treat allergic disease.

Authors:  Laurian Jongejan; Ronald van Ree
Journal:  Curr Allergy Asthma Rep       Date:  2014-12       Impact factor: 4.806

5.  Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis.

Authors:  Johannes Waage; Marie Standl; John A Curtin; Leon E Jessen; Jonathan Thorsen; Chao Tian; Nathan Schoettler; Carlos Flores; Abdel Abdellaoui; Tarunveer S Ahluwalia; Alexessander C Alves; Andre F S Amaral; Josep M Antó; Andreas Arnold; Amalia Barreto-Luis; Hansjörg Baurecht; Catharina E M van Beijsterveldt; Eugene R Bleecker; Sílvia Bonàs-Guarch; Dorret I Boomsma; Susanne Brix; Supinda Bunyavanich; Esteban G Burchard; Zhanghua Chen; Ivan Curjuric; Adnan Custovic; Herman T den Dekker; Shyamali C Dharmage; Julia Dmitrieva; Liesbeth Duijts; Markus J Ege; W James Gauderman; Michel Georges; Christian Gieger; Frank Gilliland; Raquel Granell; Hongsheng Gui; Torben Hansen; Joachim Heinrich; John Henderson; Natalia Hernandez-Pacheco; Patrick Holt; Medea Imboden; Vincent W V Jaddoe; Marjo-Riitta Jarvelin; Deborah L Jarvis; Kamilla K Jensen; Ingileif Jónsdóttir; Michael Kabesch; Jaakko Kaprio; Ashish Kumar; Young-Ae Lee; Albert M Levin; Xingnan Li; Fabian Lorenzo-Diaz; Erik Melén; Josep M Mercader; Deborah A Meyers; Rachel Myers; Dan L Nicolae; Ellen A Nohr; Teemu Palviainen; Lavinia Paternoster; Craig E Pennell; Göran Pershagen; Maria Pino-Yanes; Nicole M Probst-Hensch; Franz Rüschendorf; Angela Simpson; Kari Stefansson; Jordi Sunyer; Gardar Sveinbjornsson; Elisabeth Thiering; Philip J Thompson; Maties Torrent; David Torrents; Joyce Y Tung; Carol A Wang; Stephan Weidinger; Scott Weiss; Gonneke Willemsen; L Keoki Williams; Carole Ober; David A Hinds; Manuel A Ferreira; Hans Bisgaard; David P Strachan; Klaus Bønnelykke
Journal:  Nat Genet       Date:  2018-07-16       Impact factor: 38.330

Review 6.  Comparative analysis of allergic rhinitis in children and adults.

Authors:  Adriana Izquierdo-Domínguez; Antonio L Valero; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

7.  Association of self-reported nasal blockage with sleep-disordered breathing and excessive daytime sleepiness in Pakistani employed adults.

Authors:  Syed Fayyaz Hussain; Yona Keich Cloonan; Mohammad H Rahbar; Muhammad Islam
Journal:  Sleep Breath       Date:  2009-12-03       Impact factor: 2.816

8.  Comparison of allergic diseases, symptoms and respiratory infections between Finnish and Russian school children.

Authors:  Timo Hugg; Risto Ruotsalainen; Maritta S Jaakkola; Vadim Pushkarev; Jouni J K Jaakkola
Journal:  Eur J Epidemiol       Date:  2008-01-17       Impact factor: 8.082

9.  Specific immunotherapy-indications and mode of action.

Authors:  Randolf Brehler; Ludger Klimek; Matthias Volkmar Kopp; Johann Christian Virchow
Journal:  Dtsch Arztebl Int       Date:  2013-03-01       Impact factor: 5.594

10.  Impact on allergic immune response after treatment with vitamin A.

Authors:  Victor Matheu; Karin Berggård; Yvelise Barrios; Ysamar Barrios; Maria-Rosa Arnau; Jose M Zubeldia; Maria L Baeza; Ove Back; Shohreh Issazadeh-Navikas
Journal:  Nutr Metab (Lond)       Date:  2009-10-23       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.